Palm Beach Gardens Medical Center Now Offering the CORI™ Surgical System for Knee Replacement Surgery

Palm Beach Gardens Medical Center is now offering patients the CORI™ Surgical System for knee replacement surgery.

The CORI™ Surgical System uses handheld robotics-assisted technology helping the surgeon plan and perform the procedure.  It also gives surgeons a three-dimensional view to help finalize and verify the selection of the knee implant and create a plan for surgery without the need for either a CT scan or MRI.

“This new technology gives our community an additional innovative orthopedic procedure designed to allow patients to have normal function in their knee, and return to their daily activities,” said Teresa Urquhart, chief executive officer at Palm Beach Gardens Medical Center.  “We are committed to bringing some of the latest technologies to our area so we can give our patients quality treatment options close to home.”

Robotics-assisted knee replacement surgery using the CORITM Surgical System can lead to the following patient benefits:

  • Quicker, smoother recovery
  • Regain function faster and return home sooner
  • A unique 3D digital model to get a surgical plan customized to the patients’ unique anatomy. The surgeon can perform the procedure more accurately than traditional knee replacement surgery.
  • A natural fit: Using these technologies patients can keep more of their natural bone and ligaments, including the ACL. 6 That helps maintain more of a natural rhythm and step.
  • A wide selection: The surgeon is able to choose from the widest selection of implants available, so implants can be precision-matched to feel more like a patient’s own knee.

At Palm Beach Gardens Medical Center, we are here to offer you some of the best orthopedic care in the community. We also have a new orthopedic unit featuring a quiet, private setting with one-on-one personalized care.

Some of the accommodations of this unit include:

  • 15 private rooms with sofa beds for your family and visitors
  • Fully equipped gym for physical and occupational rehabilitation furnished with various daily activity simulators to prepare you for post-surgery
  • Car simulation
  • Bathroom set-up
  • Stair preparation
  • Spacious patient, family and visitor dining area

For more information contact the Director of Orthopedic Service Line/Nurse Navigator at 855-769-2969 or go to www.pbgmc.com.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version